Share Price and Basic Stock Data
Last Updated: November 18, 2025, 10:51 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Albert David Ltd, operating in the pharmaceuticals sector, reported a current market price of ₹838 and a market capitalization of ₹479 Cr. The company has demonstrated fluctuating sales performance, with reported sales of ₹341 Cr for the fiscal year ending March 2023, a slight increase from ₹313 Cr in the previous fiscal year. The trailing twelve months (TTM) sales stood at ₹327 Cr. Quarterly sales figures reveal variability, peaking at ₹93.20 Cr in June 2022 and declining to ₹74.57 Cr in December 2022, before rebounding to ₹93.18 Cr by September 2023. This inconsistency in revenue generation may reflect broader market challenges or competitive pressures within the pharmaceutical industry. The company’s operational performance has also shown signs of strain, with sales for the fiscal year expected to remain around ₹345 Cr for March 2025, indicating a potential stagnation in growth amid changing market dynamics.
Profitability and Efficiency Metrics
Albert David Ltd’s profitability metrics present a concerning picture, with a reported operating profit margin (OPM) of -15.11% as of March 2025, a significant decline from previous years, highlighting operational inefficiencies. The operating profit for the fiscal year 2025 was merely ₹3 Cr, down from ₹44 Cr in 2023. The net profit also reflected this downturn, recorded at ₹17 Cr for March 2025, a sharp drop from ₹36 Cr the prior year. The return on equity (ROE) stood at 4.39%, indicating low profitability relative to shareholder equity. The company’s interest coverage ratio (ICR) reported an impressive 79.45x, suggesting it can comfortably meet its interest obligations, though this may not mitigate the overall profitability challenges. Efficiency ratios like the cash conversion cycle (CCC) have increased to 112 days, signaling potential issues in working capital management that could hinder liquidity and operational performance.
Balance Sheet Strength and Financial Ratios
Albert David Ltd’s balance sheet reflects a conservative financial structure, with total borrowings reported at ₹12 Cr against total reserves of ₹387 Cr, resulting in a low debt-to-equity ratio of 0.02. This indicates minimal financial leverage and a strong equity base, which is a positive aspect for risk-averse investors. The book value per share was ₹687.70 as of March 2025, an increase from ₹671.05 in March 2024, reflecting solid reserve accumulation. However, the company’s return on capital employed (ROCE) notably declined to 6.29% for the same period, indicating challenges in efficiently utilizing capital to generate profits. Financial ratios such as the current ratio of 3.40 and quick ratio of 2.79 suggest robust liquidity positions, enabling the company to meet short-term obligations. Despite these strengths, the declining profitability metrics and operational inefficiencies warrant caution from investors.
Shareholding Pattern and Investor Confidence
The shareholding structure of Albert David Ltd reveals a stable promoter holding of 62.23% as of March 2025, reflecting strong insider confidence. Foreign institutional investors (FIIs) constituted 1.00%, while domestic institutional investors (DIIs) accounted for 1.64% of the total shareholding, indicating limited institutional interest. The public shareholding stood at 35.12%, with a total of 14,666 shareholders, suggesting a diversified ownership base. The increasing number of shareholders from 10,010 in December 2022 to 15,304 in March 2025 may signal growing retail interest, despite the company’s recent operational challenges. However, the low participation from FIIs and DIIs may reflect apprehension regarding the firm’s profitability outlook, which could impact future capital inflows. Investor confidence appears tempered, aligning with the company’s declining profitability and efficiency ratios.
Outlook, Risks, and Final Insight
Albert David Ltd faces a mixed outlook characterized by both strengths and risks. The company’s low debt levels and strong liquidity ratios position it well to weather short-term operational challenges. However, significant risks include declining profitability metrics, as evidenced by a negative operating profit margin and reduced net profit, which may deter potential investors. Additionally, the rising cash conversion cycle indicates potential inefficiencies in managing receivables and inventory, posing further operational risks. If the company can implement effective cost management strategies and improve operational efficiencies, it may stabilize and enhance profitability. Conversely, failure to address these issues could lead to continued financial strain, affecting shareholder value. The future trajectory will depend on the company’s ability to adapt to market demands and operational challenges in the competitive pharmaceutical landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Albert David Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Lactose (India) Ltd | 159 Cr. | 126 | 247/84.3 | 35.2 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.52 Cr. | 1.84 | 4.33/1.82 | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 | |
| Gujarat Themis Biosyn Ltd | 4,872 Cr. | 447 | 479/192 | 101 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 32.9 Cr. | 44.3 | 92.2/37.2 | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 | |
| Gujarat Inject (Kerala) Ltd | 38.6 Cr. | 26.4 | 29.1/17.0 | 91.9 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Industry Average | 20,295.28 Cr | 1,188.50 | 53.48 | 202.28 | 0.34% | 16.24% | 14.95% | 6.10 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 93.20 | 92.38 | 74.57 | 81.42 | 91.95 | 93.18 | 88.28 | 89.06 | 89.36 | 98.44 | 83.08 | 74.89 | 70.57 |
| Expenses | 80.99 | 78.13 | 66.28 | 71.83 | 78.96 | 77.21 | 79.92 | 79.49 | 88.48 | 92.22 | 82.40 | 79.64 | 81.23 |
| Operating Profit | 12.21 | 14.25 | 8.29 | 9.59 | 12.99 | 15.97 | 8.36 | 9.57 | 0.88 | 6.22 | 0.68 | -4.75 | -10.66 |
| OPM % | 13.10% | 15.43% | 11.12% | 11.78% | 14.13% | 17.14% | 9.47% | 10.75% | 0.98% | 6.32% | 0.82% | -6.34% | -15.11% |
| Other Income | -5.60 | 13.53 | 7.46 | 0.01 | 18.13 | 12.10 | 16.88 | 10.44 | 23.06 | 20.64 | -9.01 | -5.11 | 22.04 |
| Interest | 0.11 | 0.13 | 0.11 | 0.11 | 0.08 | 0.06 | 0.12 | 0.07 | 0.09 | 0.06 | 0.13 | 0.13 | 0.55 |
| Depreciation | 2.12 | 2.07 | 2.06 | 2.30 | 1.85 | 1.46 | 1.68 | 1.83 | 1.79 | 1.67 | 1.70 | 1.82 | 2.39 |
| Profit before tax | 4.38 | 25.58 | 13.58 | 7.19 | 29.19 | 26.55 | 23.44 | 18.11 | 22.06 | 25.13 | -10.16 | -11.81 | 8.44 |
| Tax % | 59.82% | 21.31% | 22.39% | 48.12% | 19.53% | 23.54% | 20.14% | 28.77% | 14.60% | 28.09% | -7.68% | -12.53% | 5.92% |
| Net Profit | 1.76 | 20.14 | 10.55 | 3.73 | 23.49 | 20.30 | 18.72 | 12.91 | 18.84 | 18.07 | -9.39 | -10.33 | 7.94 |
| EPS in Rs | 3.08 | 35.29 | 18.49 | 6.54 | 41.16 | 35.57 | 32.80 | 22.62 | 33.01 | 31.66 | -16.45 | -18.10 | 13.91 |
Last Updated: August 20, 2025, 2:05 pm
Below is a detailed analysis of the quarterly data for Albert David Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 70.57 Cr.. The value appears to be declining and may need further review. It has decreased from 74.89 Cr. (Mar 2025) to 70.57 Cr., marking a decrease of 4.32 Cr..
- For Expenses, as of Jun 2025, the value is 81.23 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 79.64 Cr. (Mar 2025) to 81.23 Cr., marking an increase of 1.59 Cr..
- For Operating Profit, as of Jun 2025, the value is -10.66 Cr.. The value appears to be declining and may need further review. It has decreased from -4.75 Cr. (Mar 2025) to -10.66 Cr., marking a decrease of 5.91 Cr..
- For OPM %, as of Jun 2025, the value is -15.11%. The value appears to be declining and may need further review. It has decreased from -6.34% (Mar 2025) to -15.11%, marking a decrease of 8.77%.
- For Other Income, as of Jun 2025, the value is 22.04 Cr.. The value appears strong and on an upward trend. It has increased from -5.11 Cr. (Mar 2025) to 22.04 Cr., marking an increase of 27.15 Cr..
- For Interest, as of Jun 2025, the value is 0.55 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.13 Cr. (Mar 2025) to 0.55 Cr., marking an increase of 0.42 Cr..
- For Depreciation, as of Jun 2025, the value is 2.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.82 Cr. (Mar 2025) to 2.39 Cr., marking an increase of 0.57 Cr..
- For Profit before tax, as of Jun 2025, the value is 8.44 Cr.. The value appears strong and on an upward trend. It has increased from -11.81 Cr. (Mar 2025) to 8.44 Cr., marking an increase of 20.25 Cr..
- For Tax %, as of Jun 2025, the value is 5.92%. The value appears to be increasing, which may not be favorable. It has increased from -12.53% (Mar 2025) to 5.92%, marking an increase of 18.45%.
- For Net Profit, as of Jun 2025, the value is 7.94 Cr.. The value appears strong and on an upward trend. It has increased from -10.33 Cr. (Mar 2025) to 7.94 Cr., marking an increase of 18.27 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.91. The value appears strong and on an upward trend. It has increased from -18.10 (Mar 2025) to 13.91, marking an increase of 32.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:48 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 287 | 317 | 318 | 293 | 285 | 316 | 320 | 246 | 313 | 341 | 362 | 345 | 316 |
| Expenses | 254 | 281 | 286 | 266 | 267 | 286 | 289 | 227 | 272 | 297 | 315 | 342 | 328 |
| Operating Profit | 33 | 37 | 31 | 27 | 18 | 30 | 30 | 19 | 41 | 44 | 47 | 3 | -12 |
| OPM % | 11% | 12% | 10% | 9% | 6% | 10% | 10% | 8% | 13% | 13% | 13% | 1% | -4% |
| Other Income | 1 | 2 | 43 | 8 | 9 | 15 | 7 | 17 | 16 | 15 | 58 | 30 | 6 |
| Interest | 4 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 2 |
| Depreciation | 11 | 15 | 9 | 8 | 8 | 7 | 8 | 8 | 9 | 9 | 7 | 7 | 8 |
| Profit before tax | 18 | 20 | 63 | 26 | 18 | 38 | 29 | 27 | 47 | 51 | 97 | 25 | -16 |
| Tax % | 32% | 32% | 24% | 39% | 45% | 29% | 34% | 19% | 25% | 29% | 22% | 32% | |
| Net Profit | 13 | 14 | 48 | 16 | 10 | 27 | 19 | 22 | 35 | 36 | 75 | 17 | -15 |
| EPS in Rs | 22.02 | 24.00 | 84.10 | 27.96 | 17.24 | 46.68 | 33.59 | 38.79 | 61.78 | 63.38 | 132.15 | 30.14 | -26.42 |
| Dividend Payout % | 23% | 23% | 7% | 20% | 32% | 13% | 21% | 15% | 15% | 14% | 9% | 17% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 7.69% | 242.86% | -66.67% | -37.50% | 170.00% | -29.63% | 15.79% | 59.09% | 2.86% | 108.33% | -77.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | 235.16% | -309.52% | 29.17% | 207.50% | -199.63% | 45.42% | 43.30% | -56.23% | 105.48% | -185.67% |
Albert David Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| TTM: | -9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -2% |
| 3 Years: | -20% |
| TTM: | -91% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 13% |
| 3 Years: | 10% |
| 1 Year: | -50% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 12% |
| 3 Years: | 12% |
| Last Year: | 4% |
Last Updated: September 4, 2025, 10:40 pm
Balance Sheet
Last Updated: June 16, 2025, 12:31 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 85 | 87 | 131 | 177 | 180 | 205 | 217 | 239 | 274 | 306 | 377 | 387 |
| Borrowings | 42 | 30 | 20 | 30 | 28 | 0 | 2 | 2 | 6 | 5 | 3 | 12 |
| Other Liabilities | 66 | 71 | 67 | 71 | 76 | 84 | 95 | 95 | 116 | 106 | 112 | 107 |
| Total Liabilities | 198 | 193 | 224 | 285 | 290 | 295 | 320 | 341 | 401 | 423 | 498 | 511 |
| Fixed Assets | 67 | 49 | 44 | 87 | 83 | 77 | 91 | 84 | 88 | 80 | 83 | 99 |
| CWIP | 3 | 5 | 5 | 9 | 5 | 5 | 2 | 1 | 1 | 3 | 7 | 2 |
| Investments | 16 | 16 | 48 | 59 | 68 | 113 | 122 | 138 | 183 | 193 | 273 | 260 |
| Other Assets | 111 | 122 | 127 | 130 | 134 | 99 | 106 | 119 | 130 | 148 | 135 | 151 |
| Total Assets | 198 | 193 | 224 | 285 | 290 | 295 | 320 | 341 | 401 | 423 | 498 | 511 |
Below is a detailed analysis of the balance sheet data for Albert David Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 6.00 Cr..
- For Reserves, as of Mar 2025, the value is 387.00 Cr.. The value appears strong and on an upward trend. It has increased from 377.00 Cr. (Mar 2024) to 387.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Mar 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 9.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 107.00 Cr.. The value appears to be improving (decreasing). It has decreased from 112.00 Cr. (Mar 2024) to 107.00 Cr., marking a decrease of 5.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 511.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 498.00 Cr. (Mar 2024) to 511.00 Cr., marking an increase of 13.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 99.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2024) to 99.00 Cr., marking an increase of 16.00 Cr..
- For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 5.00 Cr..
- For Investments, as of Mar 2025, the value is 260.00 Cr.. The value appears to be declining and may need further review. It has decreased from 273.00 Cr. (Mar 2024) to 260.00 Cr., marking a decrease of 13.00 Cr..
- For Other Assets, as of Mar 2025, the value is 151.00 Cr.. The value appears strong and on an upward trend. It has increased from 135.00 Cr. (Mar 2024) to 151.00 Cr., marking an increase of 16.00 Cr..
- For Total Assets, as of Mar 2025, the value is 511.00 Cr.. The value appears strong and on an upward trend. It has increased from 498.00 Cr. (Mar 2024) to 511.00 Cr., marking an increase of 13.00 Cr..
Notably, the Reserves (387.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -9.00 | 7.00 | 11.00 | -3.00 | -10.00 | 30.00 | 28.00 | 17.00 | 35.00 | 39.00 | 44.00 | -9.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 47 | 41 | 41 | 35 | 25 | 34 | 29 | 29 | 32 | 30 | 29 |
| Inventory Days | 191 | 176 | 187 | 217 | 173 | 151 | 148 | 151 | 124 | 149 | 126 | 201 |
| Days Payable | 135 | 103 | 102 | 117 | 127 | 102 | 132 | 104 | 96 | 95 | 98 | 118 |
| Cash Conversion Cycle | 111 | 120 | 126 | 141 | 81 | 74 | 50 | 76 | 57 | 87 | 58 | 112 |
| Working Capital Days | 21 | 27 | 25 | 24 | 10 | 21 | 18 | -10 | -34 | 14 | -13 | 6 |
| ROCE % | 18% | 18% | 17% | 15% | 7% | 18% | 14% | 12% | 17% | 17% | 28% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 30.14 | 132.15 | 63.39 | 61.78 | 38.80 |
| Diluted EPS (Rs.) | 30.14 | 132.15 | 63.39 | 61.78 | 38.80 |
| Cash EPS (Rs.) | 42.35 | 144.11 | 78.36 | 77.21 | 53.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 687.70 | 671.05 | 545.93 | 489.68 | 428.20 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 687.70 | 671.05 | 545.93 | 489.68 | 428.20 |
| Dividend / Share (Rs.) | 5.00 | 11.50 | 9.00 | 9.00 | 6.00 |
| Revenue From Operations / Share (Rs.) | 605.85 | 635.10 | 598.48 | 549.33 | 433.57 |
| PBDIT / Share (Rs.) | 57.13 | 182.98 | 104.67 | 99.23 | 63.65 |
| PBIT / Share (Rs.) | 44.92 | 171.02 | 89.69 | 83.81 | 49.23 |
| PBT / Share (Rs.) | 44.20 | 170.46 | 88.90 | 82.87 | 48.09 |
| Net Profit / Share (Rs.) | 30.14 | 132.15 | 63.38 | 61.78 | 38.80 |
| PBDIT Margin (%) | 9.43 | 28.81 | 17.49 | 18.06 | 14.68 |
| PBIT Margin (%) | 7.41 | 26.92 | 14.98 | 15.25 | 11.35 |
| PBT Margin (%) | 7.29 | 26.84 | 14.85 | 15.08 | 11.09 |
| Net Profit Margin (%) | 4.97 | 20.80 | 10.59 | 11.24 | 8.94 |
| Return on Networth / Equity (%) | 4.38 | 19.69 | 11.61 | 12.61 | 9.06 |
| Return on Capital Employeed (%) | 6.29 | 24.46 | 15.77 | 16.27 | 10.77 |
| Return On Assets (%) | 3.36 | 15.14 | 8.54 | 8.75 | 6.48 |
| Total Debt / Equity (X) | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 |
| Asset Turnover Ratio (%) | 0.68 | 0.78 | 0.82 | 0.84 | 0.74 |
| Current Ratio (X) | 3.40 | 3.75 | 3.07 | 2.33 | 2.77 |
| Quick Ratio (X) | 2.79 | 3.31 | 2.55 | 1.97 | 2.33 |
| Inventory Turnover Ratio (X) | 1.30 | 1.36 | 1.41 | 1.37 | 0.93 |
| Dividend Payout Ratio (NP) (%) | 38.15 | 6.81 | 14.19 | 9.71 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 27.15 | 6.24 | 11.48 | 7.77 | 0.00 |
| Earning Retention Ratio (%) | 61.85 | 93.19 | 85.81 | 90.29 | 0.00 |
| Cash Earning Retention Ratio (%) | 72.85 | 93.76 | 88.52 | 92.23 | 0.00 |
| Interest Coverage Ratio (X) | 79.45 | 325.13 | 131.04 | 106.40 | 55.62 |
| Interest Coverage Ratio (Post Tax) (X) | 42.91 | 235.81 | 80.35 | 67.24 | 34.90 |
| Enterprise Value (Cr.) | 471.38 | 584.89 | 270.90 | 288.62 | 180.08 |
| EV / Net Operating Revenue (X) | 1.36 | 1.61 | 0.79 | 0.92 | 0.72 |
| EV / EBITDA (X) | 14.46 | 5.60 | 4.53 | 5.10 | 4.96 |
| MarketCap / Net Operating Revenue (X) | 1.34 | 1.69 | 0.85 | 0.96 | 0.86 |
| Retention Ratios (%) | 61.84 | 93.18 | 85.80 | 90.28 | 0.00 |
| Price / BV (X) | 1.18 | 1.60 | 0.93 | 1.09 | 0.87 |
| Price / Net Operating Revenue (X) | 1.34 | 1.69 | 0.85 | 0.96 | 0.86 |
| EarningsYield | 0.03 | 0.12 | 0.12 | 0.11 | 0.10 |
After reviewing the key financial ratios for Albert David Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 30.14. This value is within the healthy range. It has decreased from 132.15 (Mar 24) to 30.14, marking a decrease of 102.01.
- For Diluted EPS (Rs.), as of Mar 25, the value is 30.14. This value is within the healthy range. It has decreased from 132.15 (Mar 24) to 30.14, marking a decrease of 102.01.
- For Cash EPS (Rs.), as of Mar 25, the value is 42.35. This value is within the healthy range. It has decreased from 144.11 (Mar 24) to 42.35, marking a decrease of 101.76.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 687.70. It has increased from 671.05 (Mar 24) to 687.70, marking an increase of 16.65.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 687.70. It has increased from 671.05 (Mar 24) to 687.70, marking an increase of 16.65.
- For Dividend / Share (Rs.), as of Mar 25, the value is 5.00. This value exceeds the healthy maximum of 3. It has decreased from 11.50 (Mar 24) to 5.00, marking a decrease of 6.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 605.85. It has decreased from 635.10 (Mar 24) to 605.85, marking a decrease of 29.25.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 57.13. This value is within the healthy range. It has decreased from 182.98 (Mar 24) to 57.13, marking a decrease of 125.85.
- For PBIT / Share (Rs.), as of Mar 25, the value is 44.92. This value is within the healthy range. It has decreased from 171.02 (Mar 24) to 44.92, marking a decrease of 126.10.
- For PBT / Share (Rs.), as of Mar 25, the value is 44.20. This value is within the healthy range. It has decreased from 170.46 (Mar 24) to 44.20, marking a decrease of 126.26.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 30.14. This value is within the healthy range. It has decreased from 132.15 (Mar 24) to 30.14, marking a decrease of 102.01.
- For PBDIT Margin (%), as of Mar 25, the value is 9.43. This value is below the healthy minimum of 10. It has decreased from 28.81 (Mar 24) to 9.43, marking a decrease of 19.38.
- For PBIT Margin (%), as of Mar 25, the value is 7.41. This value is below the healthy minimum of 10. It has decreased from 26.92 (Mar 24) to 7.41, marking a decrease of 19.51.
- For PBT Margin (%), as of Mar 25, the value is 7.29. This value is below the healthy minimum of 10. It has decreased from 26.84 (Mar 24) to 7.29, marking a decrease of 19.55.
- For Net Profit Margin (%), as of Mar 25, the value is 4.97. This value is below the healthy minimum of 5. It has decreased from 20.80 (Mar 24) to 4.97, marking a decrease of 15.83.
- For Return on Networth / Equity (%), as of Mar 25, the value is 4.38. This value is below the healthy minimum of 15. It has decreased from 19.69 (Mar 24) to 4.38, marking a decrease of 15.31.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.29. This value is below the healthy minimum of 10. It has decreased from 24.46 (Mar 24) to 6.29, marking a decrease of 18.17.
- For Return On Assets (%), as of Mar 25, the value is 3.36. This value is below the healthy minimum of 5. It has decreased from 15.14 (Mar 24) to 3.36, marking a decrease of 11.78.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.68. It has decreased from 0.78 (Mar 24) to 0.68, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 3.40. This value exceeds the healthy maximum of 3. It has decreased from 3.75 (Mar 24) to 3.40, marking a decrease of 0.35.
- For Quick Ratio (X), as of Mar 25, the value is 2.79. This value exceeds the healthy maximum of 2. It has decreased from 3.31 (Mar 24) to 2.79, marking a decrease of 0.52.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.30. This value is below the healthy minimum of 4. It has decreased from 1.36 (Mar 24) to 1.30, marking a decrease of 0.06.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 38.15. This value is within the healthy range. It has increased from 6.81 (Mar 24) to 38.15, marking an increase of 31.34.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 27.15. This value is within the healthy range. It has increased from 6.24 (Mar 24) to 27.15, marking an increase of 20.91.
- For Earning Retention Ratio (%), as of Mar 25, the value is 61.85. This value is within the healthy range. It has decreased from 93.19 (Mar 24) to 61.85, marking a decrease of 31.34.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 72.85. This value exceeds the healthy maximum of 70. It has decreased from 93.76 (Mar 24) to 72.85, marking a decrease of 20.91.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 79.45. This value is within the healthy range. It has decreased from 325.13 (Mar 24) to 79.45, marking a decrease of 245.68.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 42.91. This value is within the healthy range. It has decreased from 235.81 (Mar 24) to 42.91, marking a decrease of 192.90.
- For Enterprise Value (Cr.), as of Mar 25, the value is 471.38. It has decreased from 584.89 (Mar 24) to 471.38, marking a decrease of 113.51.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 1.61 (Mar 24) to 1.36, marking a decrease of 0.25.
- For EV / EBITDA (X), as of Mar 25, the value is 14.46. This value is within the healthy range. It has increased from 5.60 (Mar 24) to 14.46, marking an increase of 8.86.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.34, marking a decrease of 0.35.
- For Retention Ratios (%), as of Mar 25, the value is 61.84. This value is within the healthy range. It has decreased from 93.18 (Mar 24) to 61.84, marking a decrease of 31.34.
- For Price / BV (X), as of Mar 25, the value is 1.18. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 1.18, marking a decrease of 0.42.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has decreased from 1.69 (Mar 24) to 1.34, marking a decrease of 0.35.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.03, marking a decrease of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Albert David Ltd:
- Net Profit Margin: 4.97%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.29% (Industry Average ROCE: 16.24%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 4.38% (Industry Average ROE: 14.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 42.91
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.79
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 53.48)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.97%
About the Company - Albert David Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Pharmaceuticals | D - Block, 3rd Floor, Gillander House, Kolkata West Bengal 700001 | adidavid@dataone.in http://www.albertdavidindia.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. A K Kothari | Executive Chairman |
| Mr. Umesh Manohar Kunte | Managing Director & CEO |
| Mrs. Prabhawati Devi Kothari | Non Executive Director |
| Mr. Hemal Kampani | Non Exe. & Ind. Director |
| Mr. Rajiv Singhi | Non Exe. & Ind. Director |
| Mr. Arindam Sarkar | Non Exe. & Ind. Director |
| Mr. Shirish G Belapure | Non Exe. & Ind. Director |
| Dr. Monjori Mitra | Non Exe. & Ind. Director |
| Mr. A V Kothari | Non Executive Director |
Albert David Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹1,164.50 |
| Previous Day | ₹1,185.10 |
FAQ
What is the intrinsic value of Albert David Ltd?
Albert David Ltd's intrinsic value (as of 18 November 2025) is 365.71 which is 55.35% lower the current market price of 819.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 468 Cr. market cap, FY2025-2026 high/low of 1,540/763, reserves of ₹387 Cr, and liabilities of 511 Cr.
What is the Market Cap of Albert David Ltd?
The Market Cap of Albert David Ltd is 468 Cr..
What is the current Stock Price of Albert David Ltd as on 18 November 2025?
The current stock price of Albert David Ltd as on 18 November 2025 is 819.
What is the High / Low of Albert David Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Albert David Ltd stocks is 1,540/763.
What is the Stock P/E of Albert David Ltd?
The Stock P/E of Albert David Ltd is .
What is the Book Value of Albert David Ltd?
The Book Value of Albert David Ltd is 690.
What is the Dividend Yield of Albert David Ltd?
The Dividend Yield of Albert David Ltd is 0.61 %.
What is the ROCE of Albert David Ltd?
The ROCE of Albert David Ltd is 6.45 %.
What is the ROE of Albert David Ltd?
The ROE of Albert David Ltd is 4.39 %.
What is the Face Value of Albert David Ltd?
The Face Value of Albert David Ltd is 10.0.